Clinical Analysis of Patients who Survived for Less than 3 Months After Brain Metastatectomy.
10.3346/jkms.2009.24.4.641
- Author:
Young Zoon KIM
1
;
Kyu Hong KIM
;
Joon Soo KIM
;
Yeong Jin SONG
;
Ki Uk KIM
;
Hyung Dong KIM
Author Information
1. Department of Neurosurgery, Masan Samsung Hospital, Sungkyunkwan University School of Medicine, Masan, Korea. unikkh@unitel.co.kr
- Publication Type:Case Reports
- Keywords:
Brain Metastasis;
Metastatectomy;
Prognosis;
Surgical Candidate;
Survival
- MeSH:
Adult;
Aged;
Brain Neoplasms/mortality/*secondary/*surgery;
Craniotomy;
Data Interpretation, Statistical;
Female;
Humans;
Male;
Middle Aged;
Neoplasm Staging;
Survival Analysis
- From:Journal of Korean Medical Science
2009;24(4):641-648
- CountryRepublic of Korea
- Language:English
-
Abstract:
In the patients with brain metastasis (BM), it is impossible to determine who will benefit from surgery because of limited survival. In an attempt to identify optimal candidates for brain metastatectomy, we analyzed patients who survived for <3 months after craniotomy for a single BM lesion. Between January 1st, 1997 and July 31st, 2007, 83 patients with a single BM underwent craniotomy. Of these patients, 25 patients (30.1%) died within 3 months of craniotomy. The primary lesions were non-small call lung cancer in 15, colon cancer in 6, and breast cancer, renal cell carcinoma, ovarian cancer, or esophageal cancer in one apiece. Of the 25 patients, 19 (79%) were of tumor stage IV and had extra-cranial metastasis. Eleven (44%) of the 25 primary cancers had a well-controlled status. Twelve patients (48%) had a Karnofsky Performance Scale (KPS) score of <70, and 13 (52%) were of Recursive Partitioning Analysis (RPA) class 3. Primary cancer status, RPA class, and functional status were found to be critical factors for consideration when selecting surgical candidates. In addition, adjuvant therapy was found to have an important role on survival.
